Jazz heads to the FDA with its $1B rare disease drug

Jazz heads to the FDA with its $1B rare disease drug

Submitted by admin on December 15, 2014 - 8:28am
Source: 
Fierce Biotech
News Tags: 
Jazz Pharmaceuticals
FDA
Defibrotide
Gentium
Headline: 
Jazz heads to the FDA with its $1B rare disease drug

Do Not Allow Advertisers to Use My Personal information